LBX Pharmacy Chain Joint Stock Company (SHA:603883)
China
· Delayed Price · Currency is CNY 14.11
+0.24 (1.73%)
Apr 29, 2026, 1:44 PM CST
SHA:603883 Revenue
LBX Pharmacy Chain Joint Stock Company had revenue of 5.48B CNY in the quarter ending March 31, 2026, with 0.85% growth. This brings the company's revenue in the last twelve months to 22.28B, up 0.13% year-over-year. In the year 2025, LBX Pharmacy Chain Joint Stock Company had annual revenue of 22.24B, down -0.54%.
Revenue (ttm)
22.28B
Revenue Growth
+0.13%
P/S Ratio
0.47
Revenue / Employee
555.24K
Employees
40,132
Market Cap
10.53B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 22.24B | -120.99M | -0.54% |
| Dec 31, 2024 | 22.36B | -79.88M | -0.36% |
| Dec 31, 2023 | 22.44B | 2.26B | 11.21% |
| Dec 31, 2022 | 20.18B | 4.48B | 28.54% |
| Dec 31, 2021 | 15.70B | 1.73B | 12.38% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Anhui Huaren Health Pharmaceutical | 5.64B |
| Yixintang Pharmaceutical Group | 17.41B |
| ShuYu Civilian Pharmacy Corp. | 9.94B |
| Luyan Pharma | 21.42B |
| DaShenLin Pharmaceutical Group | 27.52B |
| Cachet Pharmaceutical | 19.53B |
| Yifeng Pharmacy Chain | 24.51B |
| Jianzhijia Pharmaceutical Chain Group | 9.10B |